Generate a tailored SOP for Dr. Kelly Dooley. Improve your application with a focused, well-structured draft.
Kelly Dooley, MD is an Associate Professor in the Department of Medicine at Johns Hopkins University School of Medicine, where she leads the Baltimore-India Clinical Trials Unit. Her research primarily focuses on tuberculosis therapeutics, with an emphasis on Phase II clinical trials evaluating new and existing drugs for treating drug-sensitive and drug-resistant tuberculosis, as well as HIV/tuberculosis co-infection. Dr. Dooley is deeply involved in clinical trials as a Principal Investigator and Protocol Chair, contributing significantly to scientific committees including the Tuberculosis Trials Consortium, AIDS Clinical Trials Group, and IMPAACT networks. She has a special interest in optimizing tuberculosis treatment for vulnerable populations, including children and pregnant women. Dr. Dooley earned her MD from Duke University and completed her residency in internal medicine alongside a fellowship in infectious diseases at Johns Hopkins School of Medicine. She is board certified in internal medicine and infectious diseases and has held various leadership roles within the ACTG Tuberculosis TSG and related groups. With extensive experience in clinical trials, her work aims to improve outcomes for individuals affected by tuberculosis and HIV.
Department of Pathology - PhD in Pathobiology. GRE is not required.